Clinical trial
Methotrexate With or Without Cyclophosphamide in Treating Patients With…
NCT00003910 · Eastern Cooperative Oncology Group, Other · Terminated
Key facts
| NCT number | NCT00003910 |
|---|---|
| Title | Methotrexate With or Without Cyclophosphamide in Treating Patients With Lymphocytic Leukemia |
| Official title | A Phase II Study of Initial Treatment With Methotrexate in Large Granular Lymphocytic (LGL) Leukemia |
| Lead sponsor | Eastern Cooperative Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug |
| Interventions | Cyclophosphamide, Methotrexate, Prednisone |
| Enrollment | 59 |
| Start date | Sep 15, 1999 |
| Primary completion | Dec 1, 2010 |
| Completion | Mar 1, 2012 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 5, 2023 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: